ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip United States - English - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

SODIUM CHLORIDE 0.18% & GLUCOSE 4.3% I.V.infusion B.P 2003 Egypt - English - EDA (Egyptian Drug Authority)

sodium chloride 0.18% & glucose 4.3% i.v.infusion b.p 2003

otsuka egypt - injection

NS Injection Kenya - English - Pharmacy and Poisons Board

ns injection

claris otsuka private limited village - vasna chacharwadi tal. sanand - sodium chloride bp - injection - 0.9 % w/v - intravenous solutions: solutions for parenteral

OTSUKA GLUCOSE INJECTION 10% (20mL) (大塚糖液10％（20mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka glucose injection 10% (20ml) (大塚糖液10％（20ml）)

otsuka pharmaceutical factory, inc. - purified glucose - injection

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP Singapore - English - HSA (Health Sciences Authority)

compound sodium lactate intravenous infusion bp

luen wah medical company (singapore) private limited - calcium chloride; lactic acid; potassium chloride; sodium chloride; sodium hydroxide - injection - 0.027 g/100 ml - calcium chloride 0.027 g/100 ml; lactic acid 0.24 ml/100 ml; potassium chloride 0.04 g/100 ml; sodium chloride 0.6 g/100 ml; sodium hydroxide 0.115 g/100 ml

Celemin 10 Plus 10% w/ v 10% w/v Intravenous Injection Philippines - English - FDA (Food And Drug Administration)

celemin 10 plus 10% w/ v 10% w/v intravenous injection

otsuka (phils.) pharmaceutical, inc.; distributor: zyre pharmaceutical corp. - amino acids , electrolytes - 10% w/v intravenous injection - 10% w/ v

BUSULFEX busulfan 60mg/10mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

busulfex busulfan 60mg/10ml injection vial

otsuka australia pharmaceutical pty ltd - busulfan, quantity: 60 mg - injection - excipient ingredients: dimethylacetamide; macrogol 400 - busulfex is indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.

MAGNESIUM SULFATE 10% injection U.S.P 27 Egypt - English - EDA (Egyptian Drug Authority)

magnesium sulfate 10% injection u.s.p 27

otsuka egypt - injection - 10 %

Super Amp Solution 10 Tanzania - English - Tanzania Medicinces & Medical Devices Authority

super amp solution 10

otsuka pharmaceutical india private limited, india - sterilised water for injection - solution - 10

BUSULFEX® INJECTION 60 mgvial Singapore - English - HSA (Health Sciences Authority)

busulfex® injection 60 mgvial

steward cross pte ltd - busulfan - injection, solution, concentrate - 60 mg/vial - busulfan 60 mg/vial